'Remnant' Cholesterol Cut by More Than 60 Percent in New Drug Trial

Science

'Remnant' Cholesterol Cut By More Than 60 Percent In New Drug Trial

By ScienceAlert

Hopes are high for a powerful new compound aimed at lowering blood fat levels responsible for potentially fatal heart disease. In a recent trial, the oral drug, TLC-2716, lowered blood triglycerides by almost 40 percent and remnant cholesterol by mor ...Read more